The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Post hoc analysis of relationship between baseline white blood cell count and renal and hepatic function and response in a randomized phase III trial of decitabine in patients age 65 or older with acute myeloid leukemia.
Jacques Delaunay
Expert Testimony - Eisai
Grzegorz Mazur
No relevant relationships to disclose
Mark D Minden
Consultant or Advisory Role - Teva
Agnieszka Wierzbowska
No relevant relationships to disclose
Mark M. Jones
Employment or Leadership Position - Eisai
Peter G. Tarassoff
Employment or Leadership Position - Eisai
Hagop Kantarjian
Research Funding - Eisai